Clinical Trial Update: A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluated whether vitamins B6 and B12 can prevent chemotherapy-induced peripheral neuropathy in cancer patients; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Vitamin B12 (cobalamin)
• Vitamin B6 (pyridoxine)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-01-25